Study types
- preprint 8
- supplementary-materials 6
Frequent coauthors
- Andrew J. Gentles 14
- Amina Tanweer 14
- Aihui Wang 14
- Brooke E. Howitt 14
- Babak Litkouhi 14
- Corrine A. Nief 14
- Phoebe M. Hammer 14
- Vivek Charu 14
Supplemental Figure 1: Kaplan Meier Survival Curves by TCGA Molecular Subtype
Supplemental Figure 1: Kaplan Meier Survival Curves by TCGA Molecular Subtype
Supplemental Figure 2: Schoenfeld’s test of proportional hazards for multivariate Cox analysis including CINSARC and EcoTyper Classifiers.
Supplemental Figure 2: Schoenfeld’s test of proportional hazards for multivariate Cox analysis including CINSARC and EcoTyper Classifiers.
Supplemental Figure 3: EERI Values in TCGA Subtypes. A) The Stanford-EEC cohort and subgroups. B) The TCGA-UCEC cohort and subgroups. P-values generated by Whitney-Mann U test. Error bars represent 95% confidence intervals.
Supplemental Figure 3: EERI Values in TCGA Subtypes. A) The Stanford-EEC cohort and subgroups. B) The TCGA-UCEC cohort and subgroups. P-values generated by Whitney-Mann U test. Error bars represent 95% confidence intervals.
Supplemental Figure 4: Recurrence Free Survival stratified by EERI score for Stages I-IV disease in the TCGA-UCEC Cohort. Patients with EEC by stage at diagnosis. Patients were included with more than 1 year of follow-up and known endometri…
Supplemental Figure 4: Recurrence Free Survival stratified by EERI score for Stages I-IV disease in the TCGA-UCEC Cohort. Patients with EEC by stage at diagnosis. Patients were included with more than 1 year of follow-up and known endometri…
Supplemental Table 1: Genes used in EERI listed by prognostic impact.
Supplemental Table 1: Genes used in EERI listed by prognostic impact.
Supplemental Table 2: Clinical and Pathologic Variables of Cases and EERI False Negatives in both the Stanford-EEC cases and TCGA-UCEC recurrent patients
Supplemental Table 2: Clinical and Pathologic Variables of Cases and EERI False Negatives in both the Stanford-EEC cases and TCGA-UCEC recurrent patients
Supplemental Table 3: Clinical and Pathologic Variables of Controls and EERI False Positives in both the Stanford-EEC controls and TCGA-UCEC non-recurrent patients
Supplemental Table 3: Clinical and Pathologic Variables of Controls and EERI False Positives in both the Stanford-EEC controls and TCGA-UCEC non-recurrent patients